Surrogate markers in oncology practice and anticancer drug development: lessons learned from antiretroviral therapy?
Remick
Scot C
SC
D044966:Anti-Retroviral Agents / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D015415:Biomarkers / Q000032:analysis*; D015195:Drug Design; D005544:Forecasting; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D008495:Medical Oncology / Q000639:trends*; D009369:Neoplasms / Q000188:drug therapy; D011379:Prognosis; D016896:Treatment Outcome
D044966:Anti-Retroviral Agents; D000970:Antineoplastic Agents; D015415:Biomarkers